Skip to Content

Watson 371 25 mg (Loxapine 25 mg)

Pill with imprint Watson 371 25 mg is Green & White, Capsule-shape and has been identified as Loxapine succinate 25 mg. It is supplied by Watson Laboratories, Inc..

Loxapine is used in the treatment of agitation; agitated state; schizophrenia and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Watson 371 25 mg

Loxapine succinate 25 mg Watson 371 25 mg
Loxapine succinate 25 mg Watson 371 25 mg
Loxapine succinate 25 mg Watson 371 25 mg

Loxapine succinate

Watson 371 25 mg
25 mg
Green & White
18.00 mm
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Laboratories, Inc.
Inactive Ingredients:
lactose anhydrous
benzyl alcohol
edetate calcium disodium
magnesium stearate
polacrilin potassium
sodium lauryl sulfate
sodium propionate
magnesium silicate
titanium dioxide
D&C Yellow No. 10
FD&C Blue No. 1
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0902 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.